Allergy services in the UK provide specialist assessment, diagnosis, and management for a wide range of allergic conditions — from common hay fever to life-threatening anaphylaxis. Whether you are seeking NHS allergy care or considering a regulated private clinic, understanding how UK allergy services work can help you access the right support promptly. This guide covers the full spectrum of specialist allergy care in the UK: how allergic conditions are diagnosed, NHS referral pathways, evidence-based treatment options, and when to seek urgent medical help. All information aligns with current NICE, BSACI, NHS, and MHRA guidance.
Summary: UK allergy services provide specialist diagnosis and management of allergic conditions — from allergic rhinitis and food allergy to anaphylaxis — through NHS clinics, teaching hospitals, and regulated private centres, guided by NICE, BSACI, and MHRA standards.
- Specialist allergy assessment in the UK typically requires a GP referral and may include skin prick testing, specific IgE blood tests, and supervised challenge testing.
- Skin prick test and specific IgE results indicate sensitisation only and must always be interpreted alongside a thorough clinical history — a positive result alone does not confirm a clinically relevant allergy.
- Unvalidated tests such as IgG food panels, hair analysis, and applied kinesiology are not recommended by NICE, BSACI, or RCPath and may lead to unnecessary dietary restriction or delayed diagnosis.
- Patients at risk of anaphylaxis should be prescribed two adrenaline auto-injectors, receive training in their use, and carry both devices at all times.
- Allergen immunotherapy (desensitisation) is an evidence-based treatment available for selected patients with allergic rhinitis and venom allergy, and must be administered in a specialist setting with resuscitation facilities.
- Anaphylaxis is a medical emergency — call 999 immediately; administer adrenaline auto-injector into the outer mid-thigh without delay if available and the patient has been trained in its use.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Allergy Services and Specialist Care in the UK
Allergy services in the United Kingdom are provided through a network of NHS allergy clinics, specialist immunology departments, and regulated private allergy centres. These services are designed to assess, diagnose, and manage a wide range of allergic conditions, from mild seasonal hay fever to complex, life-threatening anaphylaxis. Specialist allergy care is typically delivered by consultant allergists, clinical immunologists, specialist nurses, and — particularly where dietary management is required — specialist dietitians, who work collaboratively to provide comprehensive, patient-centred care. Most NHS specialist allergy services require a GP referral.
Allergy services in the UK have historically been considered underprovided relative to the scale of need, as highlighted in Royal College of Physicians reports on allergy service provision. Patients seeking specialist allergy assessment may be referred to NHS allergy clinics attached to major teaching hospitals or, where NHS waiting times are lengthy, may choose to access regulated private allergy centres. Both paediatric and adult specialist allergy services are available, and the appropriate service will depend on the patient's age and clinical needs.
Regardless of the setting, specialist allergy services typically offer:
-
Detailed clinical history-taking to identify potential triggers
-
Skin prick testing and specific IgE blood tests, interpreted in the context of the clinical history
-
Challenge testing under controlled, supervised conditions
-
Personalised management plans, including allergen avoidance strategies and emergency action plans
The British Society for Allergy and Clinical Immunology (BSACI) maintains a 'Find an allergy clinic' directory, which can help patients and GPs identify appropriate local referral options. Patients can also search for specialist services via the NHS website. Note that listing in the BSACI directory does not in itself confer formal accreditation status.
Common Allergic Conditions and How They Are Diagnosed
Allergic conditions are among the most prevalent chronic health problems in the UK, affecting an estimated one in four people at some point in their lives. The most commonly encountered allergic conditions include:
-
Allergic rhinitis (hay fever): Triggered by airborne allergens such as pollen, dust mites, or pet dander, causing nasal congestion, sneezing, and itchy eyes
-
Asthma: Allergic asthma is characterised by airway inflammation and bronchospasm in response to specific allergens; diagnosis relies on objective tests including spirometry, reversibility testing, and fractional exhaled nitric oxide (FeNO) measurement, in line with NICE guideline NG80
-
Atopic eczema (atopic dermatitis): A chronic inflammatory skin condition; whilst some patients — particularly children with moderate-to-severe eczema — may have clinically relevant food or environmental allergen triggers, not all eczema is allergy-driven and food allergy is not a universal feature
-
Food allergies: Common triggers include peanuts, tree nuts, milk, eggs, wheat, and shellfish; reactions can range from mild urticaria to severe anaphylaxis; assessment and referral in under-19s is guided by NICE guideline CG116
-
Drug allergies: Including reactions to antibiotics such as penicillin, non-steroidal anti-inflammatory drugs (NSAIDs), and contrast media; NICE guideline CG183 sets out standards for diagnosis and management
-
Allergic contact dermatitis: A delayed (type IV) hypersensitivity reaction to substances such as nickel, fragrances, or preservatives; diagnosed by patch testing conducted by a specialist
-
Insect venom allergy: Particularly to bee and wasp stings, which can provoke systemic reactions
Diagnosis of allergic conditions involves a structured approach. A thorough clinical history remains the cornerstone of allergy assessment, helping to identify the likely allergen, the nature and timing of the reaction, and any relevant co-morbidities. This is complemented by objective testing, which may include skin prick testing (SPT), measuring the wheal-and-flare response to standardised allergen extracts, and specific IgE (sIgE) blood tests, which detect allergen-specific antibodies in the bloodstream.
It is important to note that SPT and sIgE results indicate sensitisation and must always be interpreted in the context of the clinical history; a positive result does not automatically confirm a clinically relevant allergy. Indiscriminate panel testing without clinical justification is not recommended. Total IgE is a non-specific marker and is not diagnostic of allergy when used in isolation.
In some cases, particularly for food or drug allergies, a supervised oral challenge test may be required to confirm or exclude a diagnosis. This is conducted in a controlled clinical environment with resuscitation facilities available, in line with BSACI and NICE guidance.
Following a suspected episode of anaphylaxis, serum tryptase should be sampled at the appropriate time points (ideally within 1–2 hours of symptom onset, and again at baseline after recovery), as recommended by the Resuscitation Council UK and NICE guideline CG134.
NHS Referral Pathways for Allergy Assessment
In the UK, the pathway to specialist allergy assessment typically begins with a consultation with a GP. The GP will take an initial history and may arrange targeted investigations guided by the clinical picture. Where indicated by history, specific IgE blood tests may be requested. A full blood count (to assess eosinophil levels) and total IgE may occasionally be requested but are non-specific markers and are not diagnostic screening tests for allergy; results must be interpreted alongside the clinical history.
Based on these findings, the GP may initiate empirical treatment or refer the patient to a specialist allergy clinic. NICE guidance and BSACI recommendations support referral to a specialist allergy service in a number of circumstances, including:
-
Suspected anaphylaxis or severe systemic allergic reactions
-
Unclear or complex allergy diagnoses where standard testing has been inconclusive
-
Multiple food allergies, particularly in children; referral criteria are set out in NICE guideline CG116
-
Suspected drug allergy requiring specialist investigation, in line with NICE guideline CG183
-
Consideration of allergen immunotherapy (desensitisation treatment)
-
Occupational allergy requiring specialist assessment for medicolegal or employment purposes
Referrals are made via the NHS e-Referral Service, and waiting times can vary considerably depending on the region. In areas with limited NHS allergy provision, GPs may refer patients to specialist centres in neighbouring regions or, where clinically appropriate, to dermatology, respiratory medicine, or gastroenterology services for co-existing conditions.
Patients who are concerned about waiting times or who have complex needs may also access private allergy clinics, many of which are staffed by NHS consultant allergists working in a dual capacity. It is important that any private allergy testing is conducted by appropriately qualified clinicians. Unvalidated allergy tests — such as hair analysis, applied kinesiology, and IgG food panel testing — are not recommended by NICE, BSACI, or the Royal College of Pathologists (RCPath), as they lack a robust evidence base and may lead to unnecessary dietary restriction or delayed diagnosis.
Treatment Options and Management Plans for Allergies
The management of allergic conditions in the UK is guided by evidence-based frameworks from NICE, BSACI, and the European Academy of Allergy and Clinical Immunology (EAACI). Treatment is tailored to the individual patient based on the severity of their condition, the identified allergens, and their overall health status.
Allergen avoidance remains the first-line strategy for most allergic conditions. Patients are provided with clear, practical advice on minimising exposure to identified triggers, whether dietary, environmental, or occupational. Specialist dietitian input is important where dietary allergen avoidance is required, to ensure nutritional adequacy.
Pharmacological management forms the backbone of treatment for many patients and may include:
-
Antihistamines (e.g., cetirizine, loratadine, fexofenadine): Second-generation, non-sedating antihistamines are preferred for allergic rhinitis and urticaria; they work by competitively blocking H1 histamine receptors. First-generation antihistamines (e.g., chlorphenamine) cause sedation and impair driving ability; they should be used with caution
-
Intranasal corticosteroids (e.g., fluticasone, mometasone, beclometasone): First-line treatment for moderate-to-severe allergic rhinitis, reducing mucosal inflammation; correct nasal spray technique (directing the nozzle away from the nasal septum) is important to minimise side effects
-
Intranasal antihistamines (e.g., azelastine) and combination intranasal corticosteroid/antihistamine sprays (e.g., fluticasone/azelastine): Options for patients with inadequate response to intranasal corticosteroids alone, as outlined in NICE Clinical Knowledge Summary (CKS) guidance on allergic rhinitis
-
Leukotriene receptor antagonists (e.g., montelukast): May have a role as add-on therapy in allergic rhinitis and allergic asthma; prescribers should be aware of MHRA guidance on neuropsychiatric side effects associated with montelukast
-
Topical corticosteroids and emollients: Central to the management of atopic eczema, used in a step-up approach in line with current NICE guidance (including NICE guideline CG57 for children under 12); topical steroid potency should be appropriate to the site and severity, and patients should receive advice on fingertip unit dosing
-
Bronchodilators and inhaled corticosteroids: For allergic asthma, managed in line with NICE guideline NG80
-
Adrenaline auto-injectors (AAIs) (e.g., EpiPen, Jext): Prescribed to patients at risk of anaphylaxis; patients and carers should receive training in their correct use and should carry two devices at all times. Prescribers should check current MHRA guidance on available AAI brands, as product availability may change
-
Biologic therapies: For patients with severe allergic disease inadequately controlled by standard treatments, biologic agents may be considered. Examples include omalizumab (anti-IgE) for severe allergic asthma and chronic spontaneous urticaria, mepolizumab and benralizumab for severe eosinophilic asthma, and dupilumab for moderate-to-severe atopic dermatitis and chronic rhinosinusitis with nasal polyps. These are subject to NICE Technology Appraisal guidance and are initiated by specialists
Allergen immunotherapy (AIT), also known as desensitisation, is an evidence-based treatment that modifies the underlying immune response to specific allergens. It is available as subcutaneous immunotherapy (SCIT) or sublingual immunotherapy (SLIT) and is recommended by NICE and BSACI for selected patients with allergic rhinitis (including grass pollen, tree pollen, and house dust mite allergy) and venom allergy. Peanut oral immunotherapy (e.g., Palforzia) is available for selected age groups where commissioned, subject to NICE guidance. All forms of AIT must be administered in a specialist setting with appropriate resuscitation facilities.
All patients with significant allergies should receive a written, personalised allergy management plan detailing trigger avoidance, medication use, and emergency procedures.
If you experience a suspected side effect from any allergy medicine, you can report it via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk). This applies to both prescription and over-the-counter medicines.
When to Seek Urgent Medical Advice for an Allergic Reaction
Whilst most allergic reactions are mild and manageable with over-the-counter antihistamines, some reactions can escalate rapidly and become life-threatening. It is essential that patients, carers, and healthcare professionals are able to recognise the warning signs of a severe allergic reaction (anaphylaxis) and respond promptly. Note that skin signs (such as urticaria or flushing) may be absent in anaphylaxis — do not delay treatment if airway, breathing, or circulation problems are present.
Seek emergency medical help immediately (call 999) if any of the following occur:
-
Sudden onset of throat tightening, hoarseness, or difficulty swallowing
-
Difficulty breathing, wheezing, or stridor
-
Rapid or irregular heartbeat, dizziness, or collapse
-
Swelling of the lips, tongue, or throat (angioedema)
-
Loss of consciousness or feeling faint
-
Severe abdominal pain or repetitive vomiting as part of a systemic reaction
-
Widespread urticaria (hives) accompanied by any of the above systemic features
Anaphylaxis is a medical emergency. If an adrenaline auto-injector is available and the patient has been trained in its use, it should be administered into the outer mid-thigh without delay, followed by calling 999. The patient should be laid flat with their legs raised (unless breathing is compromised, in which case they should sit upright). Patients who are pregnant should be positioned on their left side. The patient should not be asked to stand or walk. A second dose of adrenaline may be given after five minutes if symptoms do not improve and a second device is available.
Following emergency treatment, patients should be observed in hospital for an appropriate period (typically at least 6–12 hours, depending on the severity of the reaction and clinical judgement), as biphasic reactions can occur. On discharge, patients should be provided with two adrenaline auto-injectors, training in their use, and a written emergency action plan. Serum tryptase should be sampled at the appropriate time points (ideally within 1–2 hours of symptom onset, and again at baseline after recovery), as recommended by the Resuscitation Council UK and NICE guideline CG134.
Contact your GP or NHS 111 if you experience:
-
A new or unexplained allergic reaction that resolves but causes concern
-
Worsening of a known allergic condition despite current treatment
-
Side effects from allergy medications that are affecting daily life
-
Uncertainty about whether your current management plan remains appropriate
Following any episode of anaphylaxis, patients should be referred urgently to a specialist allergy clinic for full assessment, allergen identification, and provision of an emergency action plan, in line with NICE guideline CG134 and Resuscitation Council UK guidance. Prompt follow-up is essential to reduce the risk of future life-threatening reactions.
Frequently Asked Questions
How do I get a referral to an NHS allergy clinic in the UK?
You start by booking an appointment with your GP, who will take a clinical history and may arrange initial blood tests before referring you to a specialist allergy clinic via the NHS e-Referral Service. Waiting times vary by region, and in areas with limited NHS allergy provision your GP may refer you to a specialist centre in a neighbouring area or to a related specialty such as dermatology or respiratory medicine.
What is the difference between a skin prick test and a specific IgE blood test for allergies?
A skin prick test (SPT) measures the immediate wheal-and-flare skin response to standardised allergen extracts applied to the forearm, whilst a specific IgE (sIgE) blood test detects allergen-specific antibodies circulating in the bloodstream. Both tests indicate sensitisation rather than confirmed allergy, and results must always be interpreted alongside a detailed clinical history by a qualified specialist.
Are IgG food intolerance tests a reliable way to diagnose a food allergy?
No — IgG food panel tests are not a validated or recommended method for diagnosing food allergy or intolerance. NICE, BSACI, and the Royal College of Pathologists all advise against their use, as they lack a robust evidence base and can lead to unnecessary dietary restriction or delayed diagnosis of the true underlying condition.
What allergy treatments are available on the NHS in the UK?
NHS allergy treatment options include second-generation antihistamines, intranasal corticosteroids, leukotriene receptor antagonists such as montelukast, adrenaline auto-injectors for anaphylaxis risk, and biologic therapies such as omalizumab or dupilumab for severe disease — all subject to NICE guidance. Allergen immunotherapy (desensitisation) for conditions such as grass pollen allergic rhinitis and venom allergy is also available through specialist NHS centres for suitable patients.
What should I do if I think I or someone with me is having a severe allergic reaction?
Call 999 immediately if there is throat tightening, difficulty breathing, swelling of the lips or tongue, collapse, or any other sign of anaphylaxis — do not wait to see if symptoms improve on their own. If an adrenaline auto-injector is available and the person has been trained in its use, administer it into the outer mid-thigh straight away, then lay the person flat with legs raised unless breathing is difficult, and await emergency services.
Can children and adults both access specialist allergy services in the UK?
Yes — both paediatric and adult specialist allergy services are available across the UK, though they are provided separately and the appropriate service depends on the patient's age and clinical needs. For children under 19 with suspected food allergy, NICE guideline CG116 sets out referral criteria, whilst adult services follow BSACI and NICE guidance relevant to the specific condition being assessed.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
